An unusual variant of ascites: congenital chylous ascites

Authors

  • Sumit Jeena Department of Neonatology, Government Medical College and Hospital, Chhatrapati Sambhaji Nagar Maharashtra, India
  • Atul C. Londhe Department of Neonatology, Government Medical College and Hospital, Chhatrapati Sambhaji Nagar Maharashtra, India
  • Amol Joshi Department of Neonatology, Government Medical College and Hospital, Chhatrapati Sambhaji Nagar Maharashtra, India
  • L. S. Deshmukh Department of Neonatology, Government Medical College and Hospital, Chhatrapati Sambhaji Nagar Maharashtra, India
  • Hemant N. Patil Department of Neonatology, Government Medical College and Hospital, Chhatrapati Sambhaji Nagar Maharashtra, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20253800

Keywords:

Total parenteral nutrition, Octreotide, Medium chain triglycerides, Neonate

Abstract

Chylous ascites is a rare condition. It is defined as the accumulation of chyle into the peritoneal cavity in infants younger than three months. Most common cause of its occurrence is malformation of the intra-abdominal lymphatic system. Other pathological conditions like malignant neoplasms, infections, liver cirrhosis, blunt abdominal trauma and surgery injury (iatrogenic injury) can also result in chylous ascites. The objective of this case report is to describe the case of a neonate with chylous ascites, establishing its diagnosis and the proposed medical treatment. A late preterm, female neonate born at 36 weeks of gestation with moderate abdominal distension was admitted in NICU and managed conservatively. At day 2 of life, diagnostic and therapeutic ascitic fluid tapping was done. Initial evaluation revealed normal blood and ascitic fluid investigations. Triglycerides were also normal (40 gm/dl) and done for exclusion of diagnosis of chylous ascites. Ascites was of exudative in nature, straw coloured with no malignant cells. At day 12 of life, in abdominal paracentesis ascitic fluid was cloudy in appearance with high triglycerides (1342 mg/dl), diagnostic of chylous ascites. Neonate was managed with withholding breastfeeding, medium chain triglyceride based rich diet, high protein diet, injection octreotide along with abdominal girth monitoring and close follow-up. Neonatal ascites improved gradually during 2 months of medical treatment following which breast feeding was introduced since long chain fatty acids are important for optimal brain growth in neonates and the baby started gaining weight.

Metrics

Metrics Loading ...

References

Huang Q, Ge BJ, Liu LM, Tu ZY, Zhang GF, Fan YZ. Successful management of chylous ascites with total parenteral nutrition, somatostatin, and fibrin glue. Chin Med J (Engl). 2007;120(20):1847-9. DOI: https://doi.org/10.1097/00029330-200710020-00024

Petropoulos AS, Sfougaris DK, Mouravas VK. Birth defects of the lymphatic system. In: Gaslem NA, editor. New developments n birth defects research. New York. Nova Science Publishers, Inc. 2007;1-67.

Jalili F. Medium-chain triglycerides and total parenteral nutrition in the management of infants with congenital chylothorax. South Med J. 1987;80:1290-3. DOI: https://doi.org/10.1097/00007611-198710000-00020

Olivieri C, Nanni L, Masini L, Pintus C. Successful management of congenital chylous ascites with early octreotide and total parenteral nutrition in a newborn. BMJ Case Rep. 2012;2012:bcr2012006196. DOI: https://doi.org/10.1136/bcr-2012-006196

R. Bhardwaj, H. Vaziri, A. Gautam, E. Ballesteros, D. Karimeddini, G. Y. Wu, Chylous Ascites: A Review of Pathogenesis, Diagnosis and Treatment. Clin. Transl. Hepatol. 2018;6:105-13. DOI: https://doi.org/10.14218/JCTH.2017.00035

Epaud R, Dubern B, Larroquet M, Aline T, Nathalie G, Chantal M, et al. Therapeutic strategies for idiopathic chylothorax. J Pediatr Surg. 2008;43(3):461-5. DOI: https://doi.org/10.1016/j.jpedsurg.2007.10.024

Bellini C, Ergaz Z, Radicioni M, Forner-Cordero I, Witte M, Perotti G, et al. Congenital fetal and neonatal visceral chylous effusions: neonatal chylothorax and chylous ascites revisited. A multi-center retrospective study. Lymphology. 2012;45(3):91-102.

Mc Gibbon A, Chen GI, Peltekian KM, Van Zanten SV. An evidence-based manual for abdominal paracentesis. Digest Disea Sci. 2007;52(12):3307-15. DOI: https://doi.org/10.1007/s10620-007-9805-5

Huang Y, Zhuang S, Li Y, Liu M, Chen H, Du M. Successful Premature Infant Congenital Chylous Ascites in a Management of Using Somatostatin Analogue. Indian Pediatr. 2010;78(3):345-7. DOI: https://doi.org/10.1007/s12098-010-0256-1

Shah BNL. The Use of Medium- Chain Triglycerides in Gastrointestinal Disorders. Pract. Gastroenterol. 2017;16:20-8.

Cardenas A Chopra S. Chylous ascites. Am J GastroenteroI. 2002;97:1896-900. DOI: https://doi.org/10.1111/j.1572-0241.2002.05911.x

Karagol BS, Zenciroglu A, Gokce S, undak AA, Ipek MS. Therapeutic hanagement of neonatal chylous ascites:report of a case and review of the lterature. Acta Paediat. 2010;99(9):1307-10. DOI: https://doi.org/10.1111/j.1651-2227.2010.01818.x

Pessotti F, Jatene IB, Buononato PE, Elilas PF, Pinto AC, Kok MF. Uso do octreotide no tratamento do quilotóraxe quiloperitoneo. Arq Bras Cardiol. 201:97(2):e33.

Yang C, Zhang J, Wang S, LI CC, Kong XR, Zhao Z. Successful management of chylous ascites with total parenteral nutrition and octreotide in children. Nutr Hosp. 2013;28(6):2124-7.

Downloads

Published

2025-11-25

How to Cite

Jeena, S., Londhe, A. C., Joshi, A., Deshmukh, L. S., & Patil, H. N. (2025). An unusual variant of ascites: congenital chylous ascites. International Journal of Contemporary Pediatrics, 12(12), 2074–2077. https://doi.org/10.18203/2349-3291.ijcp20253800

Issue

Section

Case Reports